2022 - IHE

Nilsson K, Fridhammar A, Wahlberg K, Steen Carlsson K The economic burden of overweight and obesity in Swedish children – A lifetime perspective IHE Report 2022:12, IHE: Lund, Sweden
Persson E, Svanberg N, Scherman J, Jamtheim Gustafsson C, Fridhammar A, Hjalte F, Bäck S, Nilsson P, Gunnlaugsson A, Olsson L E MRI-only radiotherapy from an economic perspective: Can new techniques in prostate cancer treatment be cost saving? Clinical and Translational Radiation Oncology, 2023; 38(January): 183-187
Open Access Published: November 21, 2022
DOI: https://doi.org/10.1016/j.ctro.2022.11.012
Kellerborg K, Norlin JM, Odin P The relationship between PDQ-8 and costs in Parkinson’s Disease – A Swedish register-based study Movement Disorder clinical practice, 2022
First published: 02 December 2022
Hofmarcher T, Lindgren P, Wilking N Cancer Care in Türkiye in a European Context IHE Report 2022:10, IHE: Lund, Sweden
Löfvendahl S, Norlin JM, Schmitt-Egenolf M Comorbidities in patients with generalized pustular psoriasis- a nationwide population-based register study Journal of the American Academy of Dermatology, Oct 2022, Online ahead of print
DOI: 10.1016/j.jaad.2022.09.049
Åström DO, Simonsen J, Raket LL, Sgarbi S, Hellsten J, Hagell P, Norlin JM, Kellerborg K, Martinez-Martin P, Odin P High risk of developing dementia in Parkinson’s disease: a Swedish registry-based study Scientific Reports 12, 16759 (2022)
DOI: https://doi.org/10.1038/s41598-022-21093-8
Hofmarcher T, Ericson O, Lindgren P Cancer in Ireland – Disease Burden, Costs and Access to Medicines IHE Report 2022:4, IHE: Lund, Sweden
Hofmarcher T, Lindgren P, Wilking N Systemic anti-cancer therapy patterns in advanced non-small cell lung cancer in Europe Journal of Cancer Policy, 2022
Version of Record 22 September 2022
DOI: https://doi.org/10.1016/j.jcpo.2022.100362
Di Tanna GL, Angell B, Urbich M, Lindgren P, Gaziano TH, Globe G, Stollenwerk B A Proposal of a Cost-Effectiveness Modeling Approach for Heart Failure Treatment Assessment: Considering the Short- and Long-Term Impact of Hospitalization on Event Rates PharmacoEconomics (2022).
Published online 12 August 2022
DOI: https://doi.org/10.1007/s40273-022-01174-2
Skarping I, Nilsson K, Dihge L, Fridhammar A, Ohlsson M, Huss L, Bendahl PO, Steen Carlsson K, Rydén L The implementation of a noninvasive lymph node staging (NILS) preoperative prediction model is cost effective in primary breast cancer Breast Cancer Research and Treatment, 2022 Aug;194(3):577-586
DOI: 10.1007/s10549-022-06636-x